BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18045726)

  • 1. Predicting cell-penetrating peptides.
    Hansen M; Kilk K; Langel U
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):572-9. PubMed ID: 18045726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-penetrating peptides: tools for intracellular delivery of therapeutics.
    Deshayes S; Morris MC; Divita G; Heitz F
    Cell Mol Life Sci; 2005 Aug; 62(16):1839-49. PubMed ID: 15968462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell penetrating peptides: overview and applications to the delivery of oligonucleotides.
    Said Hassane F; Saleh AF; Abes R; Gait MJ; Lebleu B
    Cell Mol Life Sci; 2010 Mar; 67(5):715-26. PubMed ID: 19898741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo Design of Selective Membrane-Active Peptides by Enzymatic Control of Their Conformational Bias on the Cell Surface.
    Shi J; Schneider JP
    Angew Chem Int Ed Engl; 2019 Sep; 58(39):13706-13710. PubMed ID: 31268617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automatic generation of functional peptides with desired bioactivity and membrane permeability using Bayesian optimization.
    Fukunaga I; Matsukiyo Y; Kaitoh K; Yamanishi Y
    Mol Inform; 2024 Apr; 43(4):e202300148. PubMed ID: 38182544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CPPpred: prediction of cell penetrating peptides.
    Holton TA; Pollastri G; Shields DC; Mooney C
    Bioinformatics; 2013 Dec; 29(23):3094-6. PubMed ID: 24064418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of cell penetrating peptides by support vector machines.
    Sanders WS; Johnston CI; Bridges SM; Burgess SC; Willeford KO
    PLoS Comput Biol; 2011 Jul; 7(7):e1002101. PubMed ID: 21779156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncovalent Conjugation of OVA323 to ELP Micelles Increases Immune Response.
    van Strien J; Makurat M; Zeng Y; Olsthoorn R; Schneider GF; Slütter B; MacKay JA; Jiskoot W; Kros A
    Biomacromolecules; 2024 Feb; 25(2):1027-1037. PubMed ID: 38166400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial peptides with cell-penetrating activity as prophylactic and treatment drugs.
    Del Rio G; Trejo Perez MA; Brizuela CA
    Biosci Rep; 2022 Sep; 42(9):. PubMed ID: 36052730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-penetrating peptide for targeted macromolecule delivery into plant chloroplasts.
    Kumar V; Chugh A
    Appl Microbiol Biotechnol; 2022 Aug; 106(13-16):5249-5259. PubMed ID: 35821432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of Membrane Active Peptides Considering Multi-Objective Optimization for Biomedical Application.
    Röckendorf N; Nehls C; Gutsmann T
    Membranes (Basel); 2022 Feb; 12(2):. PubMed ID: 35207101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin Classification Based on FC* and GC* Features.
    Wan H; Zhang J; Ding Y; Wang H; Tian G
    Front Genet; 2021; 12():827161. PubMed ID: 35140745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-Penetrating Peptides.
    Zorko M; Langel Ü
    Methods Mol Biol; 2022; 2383():3-32. PubMed ID: 34766279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-Penetrating Peptides Predicted From CASC3, AKIP1, and AHRR Proteins.
    Porosk L; Põhako K; Arukuusk P; Langel Ü
    Front Pharmacol; 2021; 12():716226. PubMed ID: 34504427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of efficient prokaryotic cell-penetrating peptides with applications in bacterial biotechnology.
    Lee HM; Ren J; Tran KM; Jeon BM; Park WU; Kim H; Lee KE; Oh Y; Choi M; Kim DS; Na D
    Commun Biol; 2021 Feb; 4(1):205. PubMed ID: 33589718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considerations on the Rational Design of Covalently Conjugated Cell-Penetrating Peptides (CPPs) for Intracellular Delivery of Proteins: A Guide to CPP Selection Using Glucarpidase as the Model Cargo Molecule.
    Behzadipour Y; Hemmati S
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31779220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of Gemcitabine with Cell-Penetrating Peptides: A Pharmacokinetic Approach Using In Silico Tools.
    Ferreira A; Lapa R; Vale N
    Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31690028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases.
    Tsoumpra MK; Fukumoto S; Matsumoto T; Takeda S; Wood MJA; Aoki Y
    EBioMedicine; 2019 Jul; 45():630-645. PubMed ID: 31257147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encodings and models for antimicrobial peptide classification for multi-resistant pathogens.
    Spänig S; Heider D
    BioData Min; 2019; 12():7. PubMed ID: 30867681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in Cell Penetrating Peptide-Based Anticancer Therapies.
    Habault J; Poyet JL
    Molecules; 2019 Mar; 24(5):. PubMed ID: 30866424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.